Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'COMPETITIVE INHIBITOR' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 199 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Molenaar, IQ; Legnani, C; Groenland, THN; Palareti, G; Begliomini, B; Terpstra, OT; Porte, RJ
      Aprotinin in orthotopic liver transplantation: Evidence for a prohemostatic, but not a prothrombotic, effect

      LIVER TRANSPLANTATION
    2. Garrett, IR; Gutierrez, G; Mundy, GR
      Statins and bone formation

      CURRENT PHARMACEUTICAL DESIGN
    3. Royston, D
      Pro: Aprotinin should be used in patients undergoing hypothermic circulatory arrest

      JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA
    4. Garcia-Roman, N; Alvarez, AM; Toro, MJ; Montes, A; Lorenzo, MJ
      Lovastatin induces apoptosis of spontaneously immortalized rat brain neuroblasts: Involvement of nonsterol isoprenoid biosynthesis inhibition

      MOLECULAR AND CELLULAR NEUROSCIENCE
    5. Murakami, M; Goto, T; Saito, Y; Goto, S; Kochi, M; Ushio, Y
      The inhibitory effect of simvastatin on growth in malignant gliomas - withspecial reference to its local application with fibrin glue spray in vivo

      INTERNATIONAL JOURNAL OF ONCOLOGY
    6. Suzuki, M; Iwasaki, H; Fujikawa, Y; Kitahara, M; Sakashita, M; Sakoda, R
      Synthesis and biological evaluations of quinoline-based HMG-CoA reductase inhibitors

      BIOORGANIC & MEDICINAL CHEMISTRY
    7. Auclair, K; Kennedy, J; Hutchinson, CR; Vederas, JC
      Conversion of cyclic nonaketides to lovastatin and compactin by a lovC deficient mutant of Aspergillus terreus

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    8. Matsumoto, M; Misawa, S; Chiba, N; Takaku, H; Hayashi, H
      Selective nonpeptidic inhibitors of herpes simplex virus type 1 and human cytomegalovirus proteases

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    9. Ertenli, I; Kiraz, S; Ozturk, MA; Haznedaroglu, IC; Celik, I; Kirazli, S; Calguneri, M
      Plasma fibronectin- and thrombospondin-adhesive molecules during acute attacks and attack-free periods of familial Mediterranean fever

      RHEUMATOLOGY INTERNATIONAL
    10. Caroli-Bosc, FX; Le Gall, P; Pugliese, P; Delabre, B; Caroli-Bosc, C; Demarquary, JF; Delmont, JP; Rampal, P; Montet, JC
      Role of fibrates and HMG-CoA reductase inhibitors in gallstone formation epidemiological - Study in an unselected population

      DIGESTIVE DISEASES AND SCIENCES
    11. Numazawa, M; Yamada, K; Nitta, S; Sasaki, C; Kidokoro, K
      Role of hydrophilic interaction in binding of hydroxylated 3-deoxy C-19 steroids to the active site of aromatase

      JOURNAL OF MEDICINAL CHEMISTRY
    12. Misenheimer, TM; Hahr, AJ; Harms, AC; Annis, DS; Mosher, DF
      Disulfide connectivity of recombinant C-terminal region of human thrombospondin 2

      JOURNAL OF BIOLOGICAL CHEMISTRY
    13. Shiomi, M; Ito, T; Hirouchi, Y; Enomoto, M
      Fibromuscular cap composition is important for the stability of established atherosclerotic plaques in mature WHHL rabbits treated with statins

      ATHEROSCLEROSIS
    14. Breitenbach, J; Zhu, CF; Sandmann, G
      Bleaching herbicide norflurazon inhibits phytoene desaturase by competition with the cofactors

      JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
    15. Imai, K; Kudo, N; Koyama, M; Shirahata, A; Kawashima, Y
      Effects of dehydroepiandrosterone on oleic acid formation in the liver of rats, mice and guinea pigs

      JAPANESE JOURNAL OF PHARMACOLOGY
    16. Sarno, S; Reddy, H; Meggio, F; Ruzzene, M; Davies, SP; Donella-Deana, A; Shugar, D; Pinna, LA
      Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2')

      FEBS LETTERS
    17. Kawata, S; Yamasaki, E; Nagase, T; Inui, Y; Ito, N; Matsuda, Y; Inada, M; Tamura, S; Noda, S; Imai, Y; Matsuzawa, Y
      Effect of pravastatin on survival in patients with advanced hepatocellularcarcinoma. A randomized controlled trial

      BRITISH JOURNAL OF CANCER
    18. Peng, YL; Demain, AL
      Bioconversion of compactin to pravastatin by Actinomadura sp ATCC 55678

      JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC
    19. Kumar, MS; Jana, SK; Senthil, V; Shashanka, V; Kumar, SV; Sadhukhan, AK
      Repeated fed-batch process for improving lovastatin production

      PROCESS BIOCHEMISTRY
    20. Adams, JC; Tucker, RP
      The thrombospondin type 1 repeat (TSR) superfamily: Diverse proteins with related roles in neuronal development

      DEVELOPMENTAL DYNAMICS
    21. Dansette, PM; Jaoen, M; Pons, C
      HMG-CoA reductase activity in human liver microsomes: comparative inhibition by statins

      EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
    22. Eaton, MJ; Labarca, C; Eterovic, VA
      M2 mutations of the nicotinic acetylcholine receptor increase the potency of the non-competitive inhibitor phencyclidine

      JOURNAL OF NEUROSCIENCE RESEARCH
    23. Cohen, LH; van Leeuwen, REW; van Thiel, GCF; van Pelt, JF; Yap, SH
      Equally potent inhibitors of cholesterol synthesis in human hepatocytes have distinguishable effects on different cytochrome P450 enzymes

      BIOPHARMACEUTICS & DRUG DISPOSITION
    24. Nohturfft, A; Yabe, D; Goldstein, JL; Brown, MS; Espenshade, PJ
      Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes

      CELL
    25. Bonnefoy, A; Legrand, C
      Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase

      THROMBOSIS RESEARCH
    26. Andrea, H; Fischt, I; Bach, TJ
      Differential interaction of branch-specific inhibitors of isoprenoid biosynthesis with cell cycle progression in tobacco BY-2 cells

      PHYSIOLOGIA PLANTARUM
    27. Kromer, W; Postius, S; Riedel, R
      Animal pharmacology of reversible antagonism of the gastric acid pump, compared to standard antisecretory principles

      PHARMACOLOGY
    28. Cheon, HG; Kim, HJ; Mo, HK; Lee, BH; Choi, JK
      Pharmacological properties of the gastric H+/K+ ATPase inhibitor, AU-461

      PHARMACOLOGY
    29. Lambrecht, N; Munson, K; Vagin, O; Sachs, G
      Comparison of covalent with reversible inhibitor binding sites of the gastric H,K-ATPase by site-directed mutagenesis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    30. Scharnagl, H; Schliack, M; Loser, R; Nauck, M; Gierens, H; Jeck, N; Wieland, H; Gross, W; Marz, W
      The effects of lifibrol (K12.148) on the cholesterol metabolism of cultured cells: evidence for sterol independent stimulation of the LDL receptor pathway

      ATHEROSCLEROSIS
    31. Hisada, T; Salmon, M; Nasuhara, Y; Chung, KF
      Involvement of haemoxygenase-1 in ozone-induced airway inflammation and hyperresponsiveness

      EUROPEAN JOURNAL OF PHARMACOLOGY
    32. Fukushima, M; Suzuki, N; Emura, T; Yano, S; Kazuno, H; Tada, Y; Yamada, Y; Asao, T
      Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2 '-deoxyribonucleosides

      BIOCHEMICAL PHARMACOLOGY
    33. Mascaro, C; Ortiz, JA; Ramos, MM; Haro, D; Hegardt, FG
      Sterol regulatory element binding protein-mediated effect of fluvastatin on cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase transcription

      ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
    34. Hemmerlin, A; Brown, SC; Bach, TJ
      Function of mevalonate in tobacco cell proliferation

      ACTA BOTANICA GALLICA
    35. Bernkop-Schnurch, A
      Polymer/inhibitor conjugates - A promising strategy to overcome the enzymatic barrier to perorally administered (poly)peptide drugs?

      STP PHARMA SCIENCES
    36. Birk-Sorensen, L; Fuglsang, J; Sorensen, HB; Kerrigan, CL; Petersen, LC; Ravn, HB; Hjortdal, VE
      Aprotinin attenuates platelet accumulation in ischaemia-reperfusion-injured porcine skeletal muscle

      BLOOD COAGULATION & FIBRINOLYSIS
    37. Fuchs, CT; Spiteller, G
      9-(3,4-dimethyl-5-pentyl-furan-2-yl) nonanoic acid and 9-(3,4-dimethyl-5-propyl-furan-2-yl) nonanoic acid: New naturally occurring peroxidase inhibitors

      ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES
    38. Matar, P; Rozados, VR; Binda, MM; Roggero, EA; Bonfil, RD; Scharovsky, OG
      Inhibitory effect of Lovastatin on spontaneous metastases derived from a rat lymphoma

      CLINICAL & EXPERIMENTAL METASTASIS
    39. Velardi, F; Di Chirico, A; Di Rocco, C
      Blood salvage in craniosynostosis surgery

      CHILDS NERVOUS SYSTEM
    40. Carrella, M; Fong, LG; Loguercio, C; Del Piano, C
      Enhancement of fatty acid and cholesterol synthesis accompanied by enhanced biliary but not very-low-density lipoprotein lipid secretion following sustained pravastatin blockade of hydroxymethyl glutaryl coenzyme A reductasein rat liver

      METABOLISM-CLINICAL AND EXPERIMENTAL
    41. Moghadasian, MH
      Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors

      LIFE SCIENCES
    42. Sohn, SK; Chang, MS; Choi, WS; Chung, YK; Kim, KB; Woo, TW; Lee, SB; Park, CJ
      Biochemical and pharmacological characteristics of a newly synthesized H+/K+-ATPase inhibitor, YJA20379-8, 3-butyryl-4[R-1-methylbenzylamino]-8-ethoxy-1,7-naphthyridine, in pigs and rats

      JOURNAL OF PHARMACY AND PHARMACOLOGY
    43. Ravid, T; Avner, R; Polak-Charcon, S; Faust, JR; Roitelman, J
      Impaired regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase degradation in lovastatin-resistant cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    44. Kubo, I; Kinst-Hori, I
      Flavonols from saffron flower: Tyrosinase inhibitory activity and inhibition mechanism

      JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
    45. Adli, H; Bazin, R; Perret, GY
      Interaction of amiodarone and triiodothyronine on the expression of beta-adrenoceptors in brown adipose tissue of rat

      BRITISH JOURNAL OF PHARMACOLOGY
    46. Dunlop, J; Lou, ZW; McIlvain, HB
      Properties of excitatory amino acid transport in the human U373 astrocytoma cell line

      BRAIN RESEARCH
    47. Kodama, I; Kamiya, K; Toyama, J
      Amiodarone: Ionic and cellular mechanisms of action of the most promising class III agent

      AMERICAN JOURNAL OF CARDIOLOGY
    48. HEMMERLIN A; BACH TJ
      EFFECTS OF MEVINOLIN ON CELL-CYCLE PROGRESSION AND VIABILITY OF TOBACCO BY-2 CELLS

      Plant journal
    49. TEICHER BA; WONG JS; TAKEUCHI H; GRAVELIN LM; ARA G; BUXTON D
      ALLOSTERIC EFFECTORS OF HEMOGLOBIN AS MODULATORS OF CHEMOTHERAPY AND RADIATION-THERAPY IN-VITRO AND IN-VIVO

      Cancer chemotherapy and pharmacology
    50. CAIOLFA VR; GILL D; PAROLA AH
      PROBING THE ACTIVE-SITE OF ADENOSINE-DEAMINASE BY A PH RESPONSIVE FLUORESCENT COMPETITIVE INHIBITOR

      Biophysical chemistry
    51. JOSEKUTTY PC
      INHIBITION OF PLANT-GROWTH BY MEVINOLIN AND REVERSAL OF THIS INHIBITION BY ISOPRENOIDS

      South African journal of botany
    52. TAZUMA S; KAJIYAMA G; MIZUNO T; YAMASHITA G; MIURA H; KAJIHARA T; HATTORI Y; MIYAKE H; NISHIOKA T; HYOGO H; SUNAMI Y; YASUMIBA S; OCHI H; MATSUMOTO T; ABE A; ADACHI K; OMATA F; UENO F; SUGATA F; OHGURI S; SHIBATA H; KOKUBU S
      A COMBINATION THERAPY WITH SIMVASTATIN AND URSODEOXYCHOLIC ACID IS MORE EFFECTIVE FOR CHOLESTEROL GALLSTONE DISSOLUTION THAN IS URSODEOXYCHOLIC ACID MONOTHERAPY

      Journal of clinical gastroenterology
    53. HOTCHKISS KA; MATTHIAS LJ; HOGG PJ
      EXPOSURE OF THE CRYPTIC ARG-GLY-ASP SEQUENCE IN THROMBOSPONDIN-1 BY PROTEIN DISULFIDE-ISOMERASE

      Biochimica et biophysica acta. Protein structure and molecular enzymology
    54. DENESYUK AI; ZAVYALOV VP; DENESSIOUK KA; KORPELA T
      MOLECULAR-MODELS OF 2 COMPETITIVE INHIBITORS, IL-2-DELTA-2 AND IL-2-DELTA-3, GENERATED BY ALTERNATIVE SPLICING OF HUMAN INTERLEUKIN-2

      Immunology letters
    55. DRVOTA V; BLANGE I; HAGGBLAD J; SYLVEN C
      DESETHYLAMIODARONE PROLONGATION OF CARDIAC REPOLARIZATION IS DEPENDENT ON GENE-EXPRESSION - A NOVEL ANTIARRHYTHMIC MECHANISM

      Journal of cardiovascular pharmacology
    56. CORSINI A; PAZZUCCONI F; ARNABOLDI L; PFISTER P; FUMAGALLI R; PAOLETTI R; SIRTORI CR
      DIRECT EFFECTS OF STATINS ON THE VASCULAR WALL

      Journal of cardiovascular pharmacology
    57. Prabhakar, NR
      Endogenous carbon monoxide in control of respiration

      RESPIRATION PHYSIOLOGY
    58. Numazawa, M
      Development of aromatase inhibitors and analysis of their inhibitory activities

      YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN
    59. SHIMAMOTO K; LEBRUN B; YASUDAKAMATANI Y; SAKAITANI M; SHIGERI Y; YUMOTO N; NAKAJIMA T
      DL-THREO-BETA-BENZYLOXYASPARTATE, A POTENT BLOCKER OF EXCITATORY AMINO-ACID TRANSPORTERS

      Molecular pharmacology
    60. LEE SJ; HA MJ; LEE J; NGUYEN P; CHOI YH; PIRNIA F; KANG WK; WANG XF; KIM SJ; TREPEL JB
      INHIBITION OF THE 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE PATHWAY INDUCES P53-INDEPENDENT TRANSCRIPTIONAL REGULATION OF P21(WAF1 CIP1) IN HUMAN PROSTATE CARCINOMA-CELLS/

      The Journal of biological chemistry
    61. SHEPHERD J
      A TALE OF 2 TRIALS - THE WEST OF SCOTLAND CORONARY PREVENTION STUDY AND THE TEXAS CORONARY ATHEROSCLEROSIS PREVENTION STUDY

      Atherosclerosis (Amsterdam)
    62. BELLOSTA S; BERNINI F; FERRI N; QUARATO P; CANAVESI M; ARNABOLDI L; FUMAGALLI R; PAOLETTI R; CORSINI A
      DIRECT VASCULAR EFFECTS OF HMG-COA REDUCTASE INHIBITORS

      Atherosclerosis (Amsterdam)
    63. TATSUTA M; IISHI H; BABA M; ISEKI K; YANO H; UEHARA H; YAMAMOTO R; NAKAIZUMI A
      SUPPRESSION BY PRAVASTATIN, AN INHIBITOR OF P21(RAS) ISOPRENYLATION, OF HEPATOCARCINOGENESIS INDUCED BY N-NITROSOMORPHOLINE IN SPRAGUE-DAWLEY RATS

      British Journal of Cancer
    64. TAN CA; ROBERTS MF
      ENGINEERING OF THE NONSPECIFIC PHOSPHOLIPASE-C FROM BACILLUS-CEREUS -REPLACEMENT OF GLUTAMIC ACID-4 BY ALANINE RESULTS IN LOSS OF INTERFACIAL CATALYSIS AND ENHANCED PHOSPHOMONOESTERASE ACTIVITY

      Biochemistry
    65. CAPDEVILA X; CALVET Y; BIBOULET P; BIRON C; RUBENOVITCH J; DATHIS F
      APROTININ DECREASES BLOOD-LOSS AND HOMOLOGOUS TRANSFUSIONS IN PATIENTS UNDERGOING MAJOR ORTHOPEDIC-SURGERY

      Anesthesiology
    66. Capdevila, X
      The blood sparing effect of aprotinin should be revisited - In reply

      ANESTHESIOLOGY
    67. COLLI S; ELIGINI S; LALLI M; CAMERA M; PAOLETTI R; TREMOLI E
      VASTATINS INHIBIT TISSUE FACTOR IN CULTURED HUMAN MACROPHAGES - A NOVEL MECHANISM OF PROTECTION AGAINST ATHEROTHROMBOSIS

      Arteriosclerosis, thrombosis, and vascular biology
    68. KIM DH; JIN YH; RYU CH
      INHIBITION OF PAPAIN WITH 2-BENZYL-3,4-EPOXYBUTANOIC ACID-ESTERS - MECHANISTIC AND STEREOCHEMICAL PROBE FOR CYSTEINE PROTEASE CATALYSIS

      Bioorganic & medicinal chemistry
    69. FUCHS CT; SPITELLER G
      4-PENTADECYLPYRIDINE - A COMPETITIVE POLYPHENOLOXIDASE INHIBITOR

      Zeitschrift fur Naturforschung. C, A journal of biosciences
    70. YAGI Y; BEVIS DJ; HART KL; HESS GF; DINH DM; KEISER BJ; LARSEN SD; SPILMAN CH
      SCREENING FOR INHIBITORS OF THE HMG-COA REDUCTASE PROMOTER IN HEPG2 CELLS - IDENTIFICATION OF 4 NON-OXYSTEROL INHIBITORS

      Drug development research
    71. HOGG PJ; HOTCHKISS KA; JIMENEZ BM; STATHAKIS P; CHESTERMAN CN
      INTERACTION OF PLATELET-DERIVED GROWTH-FACTOR WITH THROMBOSPONDIN-1

      Biochemical journal
    72. KIM JI; CHOI YH; JAHNG Y
      SYNTHESIS AND BIOLOGICAL-ACTIVITY OF 4,5-POLYMETHYLENEPYRAZOLE-DERIVED HMG-COA REDUCTASE INHIBITORS

      Archives of pharmacal research
    73. SHARMA BC; AGARWAL DK; BAIJAL SS; SARASWAT VA
      PRAVASTATIN HAS NO EFFECT ON BILE LIPID-COMPOSITION, NUCLEATION TIME,AND GALLBLADDER MOTILITY IN PERSONS WITH NORMAL LEVELS OF CHOLESTEROL

      Journal of clinical gastroenterology
    74. GHOSH PM; MOTT GE; GHOSHCHOUDHURY N; RADNIK RA; STAPLETON ML; GHIDONI JJ; KREISBERG JI
      LOVASTATIN INDUCES APOPTOSIS BY INHIBITING MITOTIC AND POSTMITOTIC EVENTS IN CULTURED MESANGIAL CELLS

      Biochimica et biophysica acta. Molecular cell research
    75. VRTOVSNIK F; COUETTE S; PRIE D; LALLEMAND D; FRIEDLANDER G
      LOVASTATIN-INDUCED INHIBITION OF RENAL EPITHELIAL TUBULAR CELL-PROLIFERATION INVOLVES A P21(RAS) ACTIVATED, AP-1-DEPENDENT PATHWAY

      Kidney international
    76. RAITERI M; ARNABOLDI L; MCGEADY P; GELB MH; VERRI D; TAGLIABUE C; QUARATO P; FERRABOSCHI P; SANTANIELLO E; PAOLETTI R; FUMAGALLI R; CORSINI A
      PHARMACOLOGICAL CONTROL OF THE MEVALONATE PATHWAY - EFFECT ON ARTERIAL SMOOTH-MUSCLE CELL-PROLIFERATION

      The Journal of pharmacology and experimental therapeutics
    77. BISCHOFF H; ANGERBAUER R; BENDER J; BISCHOFF E; FAGGIOTTO A; PETZINNA D; PFITZNER J; PORTER MC; SCHMIDT D; THOMAS G
      CERIVASTATIN - PHARMACOLOGY OF A NOVEL SYNTHETIC AND HIGHLY-ACTIVE HMG-COA REDUCTASE INHIBITOR

      Atherosclerosis
    78. BERKHOUT TA; SIMON HM; JACKSON B; YATES J; PEARCE N; GROOT PHE; BENTZEN C; NIESOR E; KERNS WD; SUCKLING KE
      SR-12813 LOWERS PLASMA-CHOLESTEROL IN BEAGLE DOGS BY DECREASING CHOLESTEROL-BIOSYNTHESIS

      Atherosclerosis
    79. MIYAZAWA M; WATANABE H; KAMEOKA H
      INHIBITION OF ACETYLCHOLINESTERASE ACTIVITY BY MONOTERPENOIDS WITH A P-MENTHANE SKELETON

      Journal of agricultural and food chemistry
    80. HAJRI T; CHANUSSOT F; FEREZOU J; RIOTTOT M; LAFONT H; LARUELLE C; LUTTON C
      REDUCED CHOLESTEROL ABSORPTION IN HAMSTERS BY CRILVASTATIN, A NEW 3-HYDROXY-3-METHYLGLUTARYL COENZYME-A REDUCTASE INHIBITOR

      European journal of pharmacology
    81. HUANG EM; DETWILER TC; MILEV Y; ESSEX DW
      THIOL-DISULFIDE ISOMERIZATION IN THROMBOSPONDIN - EFFECTS OF CONFORMATION AND PROTEIN DISULFIDE-ISOMERASE

      Blood
    82. CHAN MMY; FONG D; HO CT; HUANG HI
      INHIBITION OF INDUCIBLE NITRIC-OXIDE SYNTHASE GENE-EXPRESSION AND ENZYME-ACTIVITY BY EPIGALLOCATECHIN GALLATE, A NATURAL PRODUCT FROM GREENTEA

      Biochemical pharmacology
    83. KANG JJ; FANG HW
      POLYCYCLIC AROMATIC-HYDROCARBONS INHIBIT THE ACTIVITY OF ACETYLCHOLINESTERASE PURIFIED FROM ELECTRIC-EEL

      Biochemical and biophysical research communications
    84. NEGREAMINOU P; VANVLIET AK; VANERCK M; VANTHIEL GCF; VANLEEUWEN REW; COHEN LH
      INHIBITION OF PROLIFERATION OF HUMAN SMOOTH-MUSCLE CELLS BY VARIOUS HMG-COA REDUCTASE INHIBITORS - COMPARISON WITH OTHER HUMAN CELL-TYPES

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    85. AOKI T; NISHIMURA H; NAKAGAWA S; KOJIMA J; SUZUKI H; TAMAKI T; WADA Y; YOKOO N; SATO F; KIMATA H; KITAHARA M; TOYODA K; SAKASHITA M; SAITO Y
      PHARMACOLOGICAL PROFILE OF A NOVEL SYNTHETIC INHIBITOR OF 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE

      Arzneimittel-Forschung
    86. GOTISGRAHAM I; HOGG PJ; MCNEIL HP
      SIGNIFICANT CORRELATION BETWEEN THROMBOSPONDIN-1 AND SERINE PROTEINASE EXPRESSION IN RHEUMATOID SYNOVIUM

      Arthritis and rheumatism
    87. ROBBINS P; FORREST M; FANNING S; ROYSTON D
      USE OF APROTININ THERAPY IN A PATIENT WITH FACTOR-V LEIDEN

      Anesthesia and analgesia
    88. DIMITROULAKOS J; YEGER H
      HMG-COA REDUCTASE MEDIATES THE BIOLOGICAL EFFECTS OF RETINOIC ACID ONHUMAN NEUROBLASTOMA-CELLS - LOVASTATIN SPECIFICALLY TARGETS P-GLYCOPROTEIN-EXPRESSING CELLS

      Nature medicine
    89. THIBAULT A; SAMID D; TOMPKINS AC; FIGG WD; COOPER MR; HOHL RJ; TREPEL J; LIANG B; PATRONAS N; VENZON DJ; REED E; MYERS CE
      PHASE-I STUDY OF LOVASTATIN, AN INHIBITOR OF THE MEVALONATE PATHWAY, IN PATIENTS WITH CANCER

      Clinical cancer research
    90. IWASAWA Y; SHIBATA J; MITSUYA M; MASAKI H; HAYASHI M; KANNO T; SAWASAKI Y; HISAKA A; KAMEI T; TOMIMOTO K
      J-104,123, A NOVEL AND ORALLY-ACTIVE INHIBITOR OF SQUALENE SYNTHASE -STEREOSELECTIVE SYNTHESIS AND CHOLESTEROL-LOWERING EFFECTS IN DOGS

      Bioorganic & medicinal chemistry letters
    91. SMIT JWA; VANERPECUM KJ; GADELLA MM; VANDEHEYNING BJM; VANBERGEHENEGOUWEN GP
      DOES THE HMG-COA REDUCTASE INHIBITOR PRAVASTATIN INFLUENCE NUCLEATIONOF CHOLESTEROL CRYSTALS IN SUPERSATURATED MODEL BILE

      European journal of gastroenterology & hepatology
    92. NARISAWA T; MOROTOMI M; FUKAURA Y; HASEBE M; ITO M; AIZAWA R
      CHEMOPREVENTION BY PRAVASTATIN, A 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE INHIBITOR, OF N-METHYL-N-NITROSOUREA-INDUCED COLON CARCINOGENESIS IN F344 RATS

      Japanese journal of cancer research
    93. KEINO H; BANNO T; OZEKI J
      TIN-PROTOPORPHYRIN PLUS PHOTOIRRADIATION INDUCES A RELEASE OF ARYLSULFATASE FROM LYSOSOMES OF RAT HEPATOCYTES IN-VITRO AND IN-VIVO

      Biomedical research
    94. SCHNEITER R; HITOMI M; IVESSA AS; FASCH EV; KOHLWEIN SD; TARTAKOFF AM
      A YEAST ACETYL-COENZYME A CARBOXYLASE MUTANT LINKS VERY-LONG-CHAIN FATTY-ACID SYNTHESIS TO THE STRUCTURE AND FUNCTION OF THE NUCLEAR MEMBRANE-PORE COMPLEX

      Molecular and cellular biology
    95. JUZLOVA P; MARTINKOVA L; KREN V
      SECONDARY METABOLITES OF THE FUNGUS MONASCUS - A REVIEW

      Journal of industrial microbiology
    96. NARISAWA T; FUKAURA Y; TANIDA N; HASEBE M; ITO M; AIZAWA R
      CHEMOPREVENTIVE EFFICACY OF LOW-DOSE OF PRAVASTATIN, AN HMG-COA REDUCTASE INHIBITOR, ON 1,2-DIMETHYLHYDRAZINE-INDUCED COLON CARCINOGENESIS IN ICR MICE

      Tohoku Journal of Experimental Medicine
    97. SMIT JWA; VANERPECUM KJ; VANBERGEHENEGOUWEN GP
      CHOLESTEROL-SYNTHESIS INHIBITORS IN CHOLESTEROL GALLSTONE DISEASE

      Scandinavian journal of gastroenterology
    98. GAISSER S; HEIDE L
      INHIBITION AND REGULATION OF SHIKONIN BIOSYNTHESIS IN SUSPENSION-CULTURES OF LITHOSPERMUM

      Phytochemistry
    99. BUNDOCK EA; DRUMMOND GS; KAPPAS A
      TISSUE DISTRIBUTION OF SYNTHETIC HEME ANALOGS - STUDIES WITH TIN, CHROMIUM, AND ZINC MESOPORPHYRINS

      Pharmacology
    100. RODGERS PA; SEIDMAN DS; WEI PL; DENNERY PA; STEVENSON DK
      DURATION OF ACTION AND TISSUE DISTRIBUTION OF ZINC PROTOPORPHYRIN IN NEONATAL RATS

      Pediatric research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/08/20 alle ore 15:45:57